Smruthi Organics Ltd
Smruthi Organics Ltd (SMRUTHIORG): company summary
The company's business has shown mixed performance, with annual revenue declining by -19.1% and annual net profit falling by -3.7%.
Smruthi Organics Ltd (SMRUTHIORG) is a micro-cap Healthcare company valued at ₹162 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Smruthi Organics Ltd last traded at ₹140.5, down 4.42% on the day.
- Recent developments
- 2026-09-30: Promoter holding remained at 64.73%, indicating no change in ownership structure. 2026-06-30: The company reported a net profit of ₹3 crore for the latest quarter, reversing a net loss of ₹1 crore in the same period a year earlier.
- Financial performance
- The company's business has shown mixed performance, with annual revenue declining by -19.1% and annual net profit falling by -3.7%. However, the latest quarter saw a significant turnaround, with revenue rising 54.3% compared to the same quarter a year earlier and net profit swinging from a loss of ₹1 crore to a profit of ₹3 crore.
- Valuation multiples
- The stock trades at 47.0 times earnings, a premium to the Healthcare median of 32.0, 2.51 times book value. It yields 0.9%.
- Things to watch
- The company's annual revenue has declined by -19.1% year-over-year, and its profit has also fallen by -3.7%. Additionally, the stock is 16.1% below its 52-week high, and the company's profit growth over the past five years has been negative at -27.4%.
- Where it stands
- Smruthi Organics Ltd ended the latest quarter with a net profit of ₹3 crore, reversing a loss from the same period a year earlier. The stock is 16.1% below its 52-week high, and annual revenue has declined by -19.1%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (7.8) and momentum (6.0), but held back by growth (0.0). Risk looks strong at 7.8, but that is offset by valuation at 0.0 and growth at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.11
- Profitable in all of the last 5 years
- Profit shrinking 27% a year
- Revenue shrinking 4% a year
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Smruthi Organics Ltd’s valuation
Free deep-dive tools · no sign-up
Smruthi Organics Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Smruthi Organics Ltd with peers
Related tools & concepts
Value Smruthi Organics Ltd with the ratios and calculators DocStoX uses in its analysis.

